Insider filing · GKOS
Marc Stapley
Director
profile →
Glaukos Corporation
GKOS · Healthcare · 31 filings in 24 months
ticker →
Marc Stapley sold $1.9M of Glaukos (GKOS)
Executed Jan 22, disclosed Jan 26, 4 days later.
Value, as filed
$1.9M
15,000 sh across 5 lots
Executed
Jan 22
the trade date, as filed
Disclosed
Jan 26
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMarc Stapley (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $6.9M of VCYT (138,051 sh × $50.12, as filed), executed Jun 4.
The name
GKOSHealthcare · Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→